Polypeptide conjugates with extended circulating half-lives
US7186797B2 · kind B2 · utility
12Cited by
4References
44Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Aug 9, 2002 |
| Grant date | Mar 6, 2007 |
| Priority date | — |
| Expiry date | Aug 9, 2022 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K38/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to compounds and methods for synthesizing compounds wherein the compounds exhibit extended circulating half-life in the blood. The increase in circulating half-life is achieved by conjugating polypeptides to binding groups that exhibit high affinity for human serum albumin.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.